People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · AI / ML, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Neural Analytics, Inc. | — | AI / ML | Series B | $81.8M | $258.0M | 2014 |
| Siamab Therapeutics, Inc. | — | Biotechnology | Seed | $8.8M | $29.5M | 2010 |
Mark Hattendorf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Hattendorf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yuri Pikover | 1 | 9 |
| John Donovan | 1 | 8 |
| Sundar Subramaniam | 1 | 6 |
| TED KOUTOUZIS | 1 | 4 |
| Kenneth Baker | 1 | 3 |
| Leo Petrossian | 1 | 3 |
| PETER KROON | 1 | 3 |
| Jeffrey Behrens | 1 | 3 |
| Roy Doumani | 1 | 3 |
| Jeremy Sohn | 1 | 3 |
| Nick Grouf | 1 | 3 |
| Stanton Rowe | 1 | 2 |
| Robert Hamilton | 1 | 2 |
| Diane Bryant | 1 | 2 |
| Stan Rowe | 1 | 2 |
| Daniel Hanchey | 1 | 1 |
| Ji Dong Mei | 1 | 1 |
| Aaron J. Green | 1 | 1 |
| Mark Laret | 1 | 1 |
| Anjan J. Chatterji | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.